How Washington’s Response to COVID-19 Impacts Pharmacy Practice
As the nation and the world contended with the emergence and spread of COVID-19 this spring, policymakers in Washington responded with unprecedented speed by enacting and implementing multiple sweeping laws and regulations to combat the virus. From major cash assistance for businesses and individuals to sweeping healthcare reforms, the COVID-19 public health emergency drove policies […]
Read More ›Unclear CBD Legislation Keeps Regulators on Edge
Since the passage of the 2018 Farm Bill, CBD-infused food and drink products have taken the marketplace by storm. You’ve probably seen it yourself in the grocery store – shelves featuring chocolate, tea, candy, and other edibles containing cannabidiol. These products are often impermissibly marketed to treat everything from anxiety to joint pain to cancer. […]
Read More ›Increasing Access to Naloxone Can Be a Lifeline in the Community
If it weren’t for naloxone, many Americans would not be alive today. From 1996 to June 2014, at least 26,000 opioid overdoses were reversed with naloxone provided by community-based organizations. Naloxone access laws correlate with a 9 to 11 percent reduction in opioid-related deaths by state. In 2017, 70,237 Americans died from drug overdoses, and […]
Read More ›Montana Board Director Talks Taking on DSCSA Requirements
Boards of pharmacy can face unexpected challenges while working to protect the public health. Here, board executive directors talk about how they worked around these obstacles. Marcie Bough, PharmD, RPh Executive Officer, Montana Board of Pharmacy What is one of the most significant challenges or issues your board addressed in the past year or so? […]
Read More ›